Amanta Healthcare IPO Day 3 Review: Should You Apply?

Amanta Healthcare, a notable name in the pharmaceutical and healthcare sector, launched its IPO recently, attracting attention from both retail and institutional investors. With the offer now in its third day, many prospective investors are eager to understand how the issue is performing in the market. The IPO’s grey market premium (GMP)-a key indicator of investor sentiment outside official channels—along with subscription numbers, provides useful insights into demand and potential listing gains. However, investing in IPOs requires careful analysis beyond just these metrics. This article takes you through the latest status of the Amanta Healthcare IPO on day 3, explains what the GMP and subscription data suggest, and helps you decide whether applying for the IPO aligns with your investment goals.